Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.
According to a recent article in Check Orphan, genetic and biochemical testing are combined in a new method of metabolic testing called the CentoMetabolic panel. The announcement comes from…
Continue Reading
Announcing A New Test for A Wide Range of Rare Metabolic Disorders
An article in BioSpace reports new information published online by the NEJM concerning Hirschsprung disease. The disease involves the absence of nerves in parts of the intestines prior to birth. Researchers…
Continue Reading
New England Journal of Medicine (NEJM) Announces Results of A Unique Study of Hirschsprung Disease Affecting Infants
A recent article in globenewswire.com news reported that the FDA has approved Fast Track Designation for AMT 130, an experimental gene therapy for the treatment of Huntington’s disease. The…
Continue Reading
The First Adeno-Associated Viral Gene Therapy for Huntington’s Disease Receives the FDA’s Fast Track Designation
An article in Austin Gastroenterology recently asks this question. It also confirmed what we already know, that genetic testing is now available to the average person and in fact,…
Continue Reading
Can We Entrust Our Health to Genetic Mail-Order Tests?
LEXINGTON, Mass. and AMSTERDAM, the Netherlands - uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, announced that the U.S. Food and Drug…
Continue Reading
uniQure Receives FDA Fast Track Designation for AMT 130 Gene Therapy for the Treatment of Huntingtons Disease
An encouraging article recently published in Sickle Cell Anemia News announced that due to the urging of pharmaceutical companies and patient advocacy groups, the FDA has produced an updated draft…
Continue Reading
New, Revised FDA Guidelines for Rare Diseases: Common Issues in Drug Development
The oral inhibitor drug gilteritinib (XOSPATA®) was recently approved by the FDA based on interim results of the clinical trial ADMIRAL, according to an article in EurekAlert for Science News. A…
Continue Reading
FDA Approved Gilteritinib May Increase Cure Rates for Mutated FLT3 Genes in AML
OncLive recently published the views of several speakers at its State of the Science Summit on breast cancer. Stephanie LaBomascus, MD gave a presentation that highlighted triple negative breast…
Continue Reading
The Latest Advances in Triple Negative Breast Cancer
The oral inhibitor drug gilteritinib (XOSPATA®) was recently approved by the USFDA based on interim results of the clinical trial ADMIRAL according to an article in EurekAlert for Science News. A total of 371 adult patients…
Continue Reading
Targeted drug for leukemia tested at Penn Medicine helps patients live longer
A recent article in the publication CheckOrphan announced encouraging results of a long term extension study sponsored by Ultragenyx involving UX007 (triheptanoin) in patients with long-chain fatty acid oxidation disorders…
Continue Reading
New Drug Application on Track for LCFAOD A Rare Autosomal Recessive Disease
A Rare Intervention For His Children’s Rare Disease An inspiring article has recently been published in the journal Nature that credits Nick Sireau, a resident of the UK, with…
Continue Reading
A Rare Intervention For His Children’s Alkaptonuria
According to a recent article from EurekAlert!, researchers used data from the Swedish Twin Registry and found that most of the 7 diseases they were studying were inherited. The second finding…
Continue Reading
Researchers in Sweden Studied 116,330 Twins and This is What They Discovered About Autoimmune Diseases
Three cases of fibrodysplasia ossificans progressiva (FOP) a rare genetic disease, were reported recently in Stat’s health issue. Wendy’s Story Wendy Weldon was a brave little nine years old when she…
Continue Reading
An International Organization Dedicated to Finding a Cure for Fibrodysplasia Ossificans Progressiva (FOP) Began with a Group of Eleven Concerned Pen Pals
A group of international scientists has been exploring using new DNA-based nanomachines for gene therapy. The nanomachines are hoped to be more effective in the treatment of oncological diseases. As…
Continue Reading
New DNA Nanomachines Taught to Fight Cancer
A recent article in the journal Nature reports that Phase 1 GAPVAC-101 First-In-Human trial is one of the first clinical trials with a goal of designing and manufacturing actively personalized vaccines…
Continue Reading
GAPVAC Project Tests An Individualized Form of Immunotherapy to Treat Aggressive Brain Cancer
M ost of the time, Whitney Weldon doesn’t think about her second skeleton. She was 9 the first time it really flared up. Bridges of bone grew from nowhere to…
Continue Reading
Patients with FOP, a grim genetic disease, see hope on the horizon
418 words 9% vs 744 words 5%Researchers in Sweden Studied 116,330 Twins and This is What They Discovered About Autoimmune DiseasesAccording to a recent article in the EurekAlert researchers used data from…
Continue Reading
Autoimmune diseases are related to each other, some more than others
A recent article in the National Hemophilia Foundation news quotes the Blood Transfusion journal's report on the results of a study conducted under the lead of Dr. Flora Peyvandi, Medical…
Continue Reading
Secondary Long-Term Prophylaxis Shows Promise for Patients with Severe von Willebrand Disease (vWD)
A recent article in Parkinson’s News Today reports that a reduction in a patient’s required medication and management of motor system disorders may be achievable with Deep-Brain Stimulation (DBS) for…
Continue Reading
Parkinson’s Patients May Benefit from Deep-Brain Stimulation (DBS)
Following a record number of approvals in 2018, the FDA has recently approved two new drugs with many more anticipated approvals later in the year. Trazimera to Treat Human Epidermal…
Continue Reading
A Record Number of FDA Drug Approvals in 2018 Is Followed by an Encouraging Start for 2019
A recent announcement by the Ehlers-Danlos Society marks the beginning of the recruitment phase for an international study devoted to determining the root cause of hEDS. The gathering of this…
Continue Reading
International Genetic Research Group to Begin Study of Hypermobile Ehlers-Danlos Syndrome (hEDS)
source: pixabay.com
According to a recent article in the Globe, the Danish biotech company Saniona AB has initiated a Phase 2a clinical trial of Tesomet for the treatment of hypothalamic obesity, a rare…
Continue Reading
A New Drug With the Potential to Treat Hypothalamic Obesity
A recent article published in online CANCER NETWORK reports findings that indicate children who have survived Hodgkin lymphoma (HL) may develop solid tumors in later years. These findings will have…
Continue Reading
For Childhood Survivors of Hodgkin Lymphoma, the Battle may not be Over
Although some ultrasound and/or CT scan studies may show that patients’ lymph nodes (glands) are free of disease, upon further examination using sentinel lymph node biopsies,(SLNB) the doctors at MD…
Continue Reading
MD Anderson Physicians Use a Diagnostic Method Called Sentinel Lymph Node Biopsy To Determine Spread of Cancer
Medical devices include ECG electrodes, bandages, cardiac pacemakers, thermometers, and hemodialysis machines. A comparison of clinical trials shows that medical device trials are somewhat similar to pharmaceutical trials that evaluate drugs,…
Continue Reading
FDA Regulations and the Critical Differences Between Medical Device Trials and Pharmaceutical Trials